|
|
|||
|
||||
OverviewEarly Vascular Aging (EVA): New Directions in Cardiovascular Protection, Second Edition continues to be the most comprehensive and authoritative resource on premature alterations in artery structure and function. The book presents a novel approach to the problem of cardiovascular disease, showing it in relation to great vessels disease and revealing a comprehensive approach to the problem of increased rigidity of the great vessels, its causes, and further consequences. This second edition contains completely updated content with expanded coverage of basic and translational research, systematic reviews of the most prominent literature, discussion of applicability of new evidence and more. Written by an international team of clinicians and researchers, this is a valuable resource to basic and translational scientists, clinical researchers and clinicians in the cardiovascular field interested in prevention, diagnosis and treatment of EVA. Full Product DetailsAuthor: Pedro Guimarães Cunha, MD, PhD (Visiting Professor at the School of Medicine, University of Minho, Portugal) , Pierre Boutouyrie, MD, PhD (Full Professor of Pharmacology and Cardiology, University Paris Descartes Sorbonne, Paris, France) , Michael Hecht Olsen (Professor, University of Southern Denmark and Odense University Hospital, Odense C, Denmark) , Peter M Nilsson, MD, PhD (Senior Professor, Cardiovascular Research, consultant, Department of Clinical Sciences, Lund University, Sweden)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Edition: 2nd edition Weight: 0.450kg ISBN: 9780443155123ISBN 10: 0443155127 Pages: 770 Publication Date: 01 March 2024 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Not yet available This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release. Table of ContentsReviewsAuthor InformationProf. Pedro Guimarães Cunha is a Consultant in Internal Medicine and a European Hypertension Specialist (by the European Society of Hypertension). He works as a Professor and Researcher of Minho Medical School and the Life and Health Sciences Research Institute, Minho University. He coordinates the Outpatient Clinic and Research of the Center for the Research and Treatment of Arterial Hypertension and Cardiovascular Risk, Hospital Senhora da Oliveira - Guimarães / Minho University (an ESH Excellence Center in Hypertension). He has served as President of the Working Group Hypertension and Brain - European Society of Hypertension (2018-2022) and is currently the Secretary General of the Executive Committee of the Artery Society. His main focus is clinical research in vascular aging, large arteries, cardiovascular risk, hypertension, cardiometabolic and cardiovascular disease. Pierre Boutouyrie is full professor of Pharmacology at Université de Paris Cité, head of Pharmacology department and cardiologist at Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, and researcher at Institut National de Santé et recherche médicale INSERM, PARCC. His main topics are care and research in hypertension, research on arterial remodeling and stiffness. He has published over 340 articles and has over 20,000 quotations. Michael Hecht Olsen is a professor in Hypertension and Cardiovascular Prevention at the Department for Regional Health Research, University of Southern Denmark, and senior consultant in cardiology at Department of Medicine 1, Holbaek Hospital, Denmark. Both clinically and in research, he works with hypertension, obesity, diabetes and cardiovascular risk stratification using measurements of subclinical cardiovascular damage (e.g., pulse wave analysis, ultrasound of the carotid arteries and echocardiography) and new biomarkers for deep phenotyping trying to develop individualized treatment. He has published over 200 publications (Web of Science H-index 47). Peter M. Nilsson is Senior Professor/expert in Clinical Cardiovascular Research at Lund University, Department of Clinical Sciences, Skåne University Hospital, Malmö, Sweden. For many years he has been developing the concept of EVA with numerous colleagues and the prevention of cardiovascular disease and type 2 diabetes. Stepane Laurent’s research interests are hypertension pathophysiology and management, pharmacology of antihypertensive drugs, arterial stiffness and vascular ageing. He has served as President of the European Society of Hypertension (ESH) (2007-2009) and President of the ARTERY Society (2010-2012), and is the author of over 500 referenced articles and 20 chapters in books. Tab Content 6Author Website:Countries AvailableAll regions |